Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention for End point reduction in hypertension (LIFE) study Academic Article uri icon

Overview

MeSH Major

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Atenolol
  • Atrial Fibrillation
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Losartan
  • Stroke

abstract

  • Our novel finding is that new-onset AF and associated stroke were significantly reduced by losartan- compared to atenolol-based antihypertensive treatment with similar blood pressure reduction.

publication date

  • March 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2004.10.068

PubMed ID

  • 15734615

Additional Document Info

start page

  • 712

end page

  • 9

volume

  • 45

number

  • 5